Search results

Filter

Filetype

Your search for "2024" yielded 20955 hits

“A tremendous impact on the transformation towards a sustainable future”

90 MSEK goes to Lund when research initiative WISE invests half a billion SEK in material science for increased sustainability – the largest investment in material science in Sweden. Photo: Kennet Ruona WISE, the Wallenberg Initiative Materials Science for Sustainability, is the largest-ever investment in materials science in Sweden and is financed by the Knut and Alice Wallenberg Foundation. WISE

https://www.nano.lu.se/article/tremendous-impact-transformation-towards-sustainable-future - 2025-08-25

Anne L’Huillier new Frontiers of Knowledge Awardee

The BBVA Foundation Frontiers of Knowledge Award in Basic Sciences goes in this fifteenth edition to Anne L’Huillier and her companions in the pioneering field of “attophysics”, Paul Corkum and Ferenc Krausz. Photo: Kennet Ruona For her pioneering work in attosecond physics, Anne L’Huillier is one of the three new laureates of the Frontiers of Knowledge Award in basic science, a prize from the BBV

https://www.nano.lu.se/article/anne-lhuillier-new-frontiers-knowledge-awardee - 2025-08-25

WHO mission: creating evidence on how health care can prevent disease

Inger Kristensson Hallström and Hanne Tønnesen, head of the WHO Collaboratoring Centre at Lund University. Photo: Jon Ulvsgärd. One in three patients is asked about their lifestyle habits when they visit the outpatient healthcare clinics. This figure really ought to be higher, according to Professors Hanne Tønnesen and Inger Kristensson Hallström, who are in charge of the WHO Collaborating Centre

https://www.medicine.lu.se/article/who-mission-creating-evidence-how-health-care-can-prevent-disease - 2025-08-25

Meet our new guest researcher, Jan de Boer

Jan de Boer is a full professor at the department of Biomedical Engineering, Eindhoven University of Technology. He is skilled in Stem Cells, Biomaterial Engineering and Regenerative Medicine. Jan de Boer is a biologist at the department of Biomedical Engineering, Eindhoven University of Technology in The Netherlands. His research interest is in the molecular complexity of cells and how molecular

https://www.pi.lu.se/en/article/meet-our-new-guest-researcher-jan-de-boer - 2025-08-25

Update STEM-PD clinical trial – stem cell-based transplant for Parkinson’s disease

Photo from stem cell transplantation at Skåne University Hospital. Source: Skåne University Hospital. Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Pa

https://www.multipark.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2025-08-25

Call for applications to the Swedish National ATMP Research School

Johan Flygare, Coordinator of the National Swedish ATMP Research School. Photo: Agata Garpenlind. Johan Flygare, Coordinator of the Swedish National ATMP Research School talks about ATMP, about the school and explains why you should apply. Deadline: 15 February. –  ATMP is personally very important to me. Since I started as Deputy Coordinator of the Stem Cell Center, a specific task I have focused

https://www.intramed.lu.se/en/article/call-applications-swedish-national-atmp-research-school - 2025-08-25

From marine research to AI and entrepreneurship – this year’s honorary doctors inspired a full house

From left: Professor Caroline Slomp, Professor Margaret-Anne Storey, entrepreneur Semmy Rülf and Professor Sabeth Verpoorte. On 22 May, the day before the university's annual doctoral ceremony, around 70 people gathered at IKDC for a joint honorary doctorate seminar organised by the Faculty of Science and LTH. Despite the downpour outside, the hall was filled with curious participants who were off

https://www.science.lu.se/internal/article/marine-research-ai-and-entrepreneurship-years-honorary-doctors-inspired-full-house - 2025-08-25

2025 is the International Year of Glaciers’ Preservation - research at LUCSUS studies impacts of glacial melt

The United Nations declared 2025 as the International Year of Glaciers' Preservation, accompanied by the proclamation of the 21st March of each year as the World Day for Glaciers starting in 2025. Around the world, glaciers are retreating at unprecedented rates due to climate change. On January 21, the United Nations General Assembly declared 2025 the International Year of Glaciers’ Preservation (

https://www.lucsus.lu.se/article/2025-international-year-glaciers-preservation-research-lucsus-studies-impacts-glacial-melt - 2025-08-25

“A tremendous impact on the transformation towards a sustainable future”

90 MSEK goes to Lund when research initiative WISE invests half a billion SEK in material science for increased sustainability – the largest investment in material science in Sweden. Photo: Kennet Ruona WISE, the Wallenberg Initiative Materials Science for Sustainability, is the largest-ever investment in materials science in Sweden and is financed by the Knut and Alice Wallenberg Foundation. WISE

https://www.fysik.lu.se/en/article/tremendous-impact-transformation-towards-sustainable-future - 2025-08-25

From enemy to friend – 33 million for reprogramming cancer cells

Filipe Pereira (R) coordinates the research project which is allocated 33 million from the EIC. Together with Fábio Fiúza Rosa (L), he is also one of the founders of the company Asgard Therapeutics, partner in the EIC project. Photo: Asgard Therapeutics An international research project led from Lund University is now awarded 33 million SEK by the European Innovation Council, EIC Pathfinder. The i

https://www.medicine.lu.se/article/enemy-friend-33-million-reprogramming-cancer-cells - 2025-08-25

Update STEM-PD clinical trial – stem cell-based transplant for Parkinson’s disease

Photo from stem cell transplantation at Skåne University Hospital. Source: Skåne University Hospital. Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Pa

https://www.medicine.lu.se/article/update-on-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2025-08-25

New precision medicine approach helps detect subgroups of people with obesity at high risk of diabetes and heart disease

Obesity is a common cause of diabetes, heart disease and early death, but risk differs greatly from one person to the next. Photo: iStock/Suriyawut Suriya Obesity is a common cause of diabetes, heart disease and early death, but risk differs greatly from one person to the next. In work led by researchers at Lund University in Sweden as part of the Innovative Medicine Initiative project SOPHIA, a p

https://www.medicine.lu.se/article/new-precision-medicine-approach-helps-detect-subgroups-people-obesity-high-risk-diabetes-and-heart - 2025-08-25

From enemy to friend – 33 million for reprogramming cancer cells

Filipe Pereira (R) coordinates the research project which is allocated 33 million from the EIC. Together with Fábio Fiúza Rosa (L), he is also one of the founders of the company Asgard Therapeutics, a partner in the EIC project. Photo: Asgard Therapeutics An international research project led from Lund University is now awarded 33 million SEK by the European Innovation Council, EIC Pathfinder. The

https://www.stemcellcenter.lu.se/article/enemy-friend-33-million-reprogramming-cancer-cells - 2025-08-25

Drawing the molecular roadmap of Human Natural Killer Cell development

Researchers studying natural killer cells present a comprehensive map of how these cells develop in humans, detailing their regulatory networks along the way. Image credit: AI-illustrated artwork via Midjourney // Dang Nghiem Vo At any given time, more than 2 billion natural killer cells patrol the adult bloodstream as frontline defenders, protecting against infections and cancer. In a recent stud

https://www.stemcellcenter.lu.se/article/drawing-molecular-roadmap-human-natural-killer-cell-development - 2025-08-25

Update on STEM-PD clinical trial – stem cell-based transplant for Parkinson’s disease

Photo from stem cell transplantation at Skåne University Hospital. Source: Skåne University Hospital. Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Pa

https://www.stemcellcenter.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2025-08-25

The gene that controls the prognosis in neuroblastoma

Sofie Mohlin's research team has discovered that the MOXD1 gene is associated with neuroblastoma. Every year, about twenty children in Sweden get neuroblastoma. Most of them are diagnosed before the age of five. Some develop the disease in the fetal stage Neuroblastoma is a tumor disease that primarily affects young children. The survival rate is the lowest of all childhood cancers. Now, a researc

https://www.stemcellcenter.lu.se/article/gene-controls-prognosis-neuroblastoma - 2025-08-25

The finance society LINC hosted new competition – won first prize!

Photo: LINC. This year, the Swedish University Pitch Competition was held for the first time for students engaged in finance associations at Swedish universities. The Lund University Finance Society, LINC, both hosted the competition and won first prize with one of their participating teams. Hello Ture Eknor, President of LINC! Can you tell us about the Swedish University Pitch Competition?“It all

https://www.lusem.lu.se/article/finance-society-linc-hosted-new-competition-won-first-prize - 2025-08-25

Blodprov minst lika bra som ryggvätskeprov på att upptäcka Alzheimers

Foto: istock.com/Gab13 I en studie som publicerats i Nature Medicine visar forskare att ett blodprov, som inom kort blir tillgängligt i USA, är lika träffsäkert – och i vissa fall överlägset – ryggvätskeprov. – Vi hoppas på att liknande test kommer att kunna användas i sjukvården i Sverige innan årets slut, säger Oskar Hansson, professor i neurologi vid Lunds universitet och en av forskarna bakom

https://www.medicin.lu.se/artikel/1/blodprov-minst-lika-bra-som-ryggvatskeprov-pa-att-upptacka-alzheimers - 2025-08-25

Genen som styr prognosen vid neuroblastom

Sofie Mohlins forskargrupp har upptäckt att genen MOXD1 är associerad med tumörsjukdomen neuroblastom. Varje år insjuknar runt tjugo barn i Sverige. Majoriteten blir sjuka innan fem års ålder. Några utvecklar sjukdomen redan i fosterstadiet. Bild: iStock. Neuroblastom är en tumörsjukdom som främst drabbar små barn. Överlevnaden är den lägsta av alla barncancerformer. Nu har en forskargrupp vid Lun

https://www.medicin.lu.se/artikel/genen-som-styr-prognosen-vid-neuroblastom - 2025-08-25